Within this context, previous studies have provided evidence for the implication of nuclear receptors (i.e., Nr4a1 and Nr4a3) in schizophrenia and bipolar disorders, demonstrating that down-regulated expression levels or sequence variations correlate with increased susceptibility to these cognitive disorders (Figure 2) [126,127,135,136]. This evidence concerns the gene NR4A3 and cognitive disorder.